(Q46074914)

19 December 2017

title

Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG. (English)

1 reference

19 December 2017

0 references

2

Peter H Sykes

1 reference

19 December 2017

John Evans

series ordinal

4

object named as

John J Evans

1 reference

19 December 2017

author name string

James M Dann

series ordinal

1

1 reference

19 December 2017

Drusilla R Mason

series ordinal

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

25 March 2009

1 reference

19 December 2017

published in

Gynecologic Oncology

1 reference

19 December 2017

volume

113

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

374-378

1 reference

19 December 2017

Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Regulation of gene expression by the hypoxia-inducible factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

A conserved family of prolyl-4-hydroxylases that modify HIF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Resveratrol: a review of preclinical studies for human cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Reduced risk of esophageal cancer associated with green tea consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

A case-control study of gastric cancer and diet in northern Kyushu, Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Green tea consumption and the risk of pancreatic and colorectal cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Influence of drinking green tea on breast cancer malignancy among Japanese patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Hypoxia-inducible factor-1 in human breast and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Diet and cancer risk in Mediterranean countries: open issues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.014

10.1016/J.YGYNO.2009.02.014

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017